A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 29. 9. 2017, under the no. SUKLS240183/2016 - I. under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 4, 5, 8 and 10 of the decision under appeal is dismissed and the proceedings are terminated II. Under article 90 paragraph 1 letter b) of the Administrative Code the decision is reversed and the matter is referred back to the State Institute for Drug Control for reappraisal.
More info MZCR.cz (czech version only)